MS-8209, a water-soluble amphotericin B derivative, affects both scrapie agent replication and PrPres accumulation in Syrian hamster scrapie

Journal of General Virology

Volumn 80, Issue 4, 1999, Pages 1079-1085

  Adjou, Karim T ^a   Demaimay, Remi ^a   Deslys, Jean Philippe ^a   Lasmézas, Corinne I ^a   Beringue, Vincent ^a   Demart, Severine ^a   Lamoury, Francois ^a   Seman, Michel ^b   Dormont, Dominique ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b INSTITUT JACQUES MONOD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DERIVATIVE; MS 8209; PRION PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; FEMALE; NONHUMAN; PRIORITY JOURNAL; SCRAPIE; SCRAPIE AGENT; SYRIAN HAMSTER; VIRUS REPLICATION;

EID: 0032934347     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-4-1079     Document Type: Article

References (39)

1. Adjou, K. T., Demaimay, R., Lasmézas, C., Deslys, J. P., Seman, M. & Dormont, D. (1995). MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie. Antimicrobial Agents and Chemotherapy 39, 2810-2812.
2. Adjou, K. T., Demaimay, R., Lasmézas, C. I., Seman, M., Deslys, J. P. & Dormont, D. (1996). Differential effects of a new amphotericin B derivative, MS-8209, on mouse BSE and scrapie: implications for the mechanism of action of polyene antibiotics. Research in Virology 147, 213-218.
3. Adjou, K. T., Deslys, J.-P., Demaimay, R. & Dormont, D. (1997). Probing the dynamics of prion diseases with amphotericin B. Trends in Microbiology 5, 27-31.
4. Adjou, K. T., Deslys, J. P., Demaimay, R., Seman, M. & Dormont, D. (1998). Prospects for the pharmacological treatment of human prion diseases. CNS Drugs 10, 83-89.
5. Amyx, H., Salazar, A.M., Gajdusek, D. C. & Gibbs, C. J. (1984). Chemotherapeutic trials in experimental slow virus disease. Neurology 34 (Suppl.), 149.
6. Bolton, D. C., McKinley, M. P. & Prusiner, S. B. (1982). Identification of a protein that purifies with the scrapie prion. Science 218, 1309-1311.
7. Brown, P. (1990). A therapeutic panorama of the spongiform encephalopathies. Antiviral Chemistry & Chemotherapy 1, 75-83.
8. Caughey, B. & Chesebro, B. (1997). Prion protein and the transmissible spongiform encephalopathies. Trends in Cell Biology 7, 56-62.
9. Demaimay, R., Adjou, K., Lasmézas, C., Lazarini, F., Cherifi, K., Seman, M., Deslys, J.-P. & Dormont, D. (1994). Pharmacological studies of a new derivative of amphotericin B, MS-8209, in mouse and hamster scrapie. Journal of General Virology 75, 2499-2503.
10. Demaimay, R., Adjou, K. T., Beringue, V., Demart, S., Lasmézas, C. I., Deslys, J.-P., Seman, M. & Dormont, D. (1997). Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals. Journal of Virology 71, 9685-9689.
11. Diringer, H. & Ehlers, B. (1991). Chemoprophylaxis of scrapie in mice. Journal of General Virology 72, 457-460.
12. Dormont, D., Delpech, B., Delpech, A., Courcel, M. N., Viret, J., Markovits, P. & Court, L. (1981). Hyperproduction de protéine gliofibrillaire acide (GFAP) au cours de l'évolution de la tremblante expérimentale de la souris. Comptes Rendus de l'Académie des Sciences de Paris 293, 53-56.
13. Ehlers, B. & Diringer, H. (1984). Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. Journal of General Virology 65, 1325-1330.
14. Georgsson, G., Gisladottir, E. & Arnadottir, S. (1993). Quantitative assessment of the astrocytic response in natural scrapie of sheep. Journal of Comparative Pathology 108, 229-240.
15. Hill, A. F., Desbruslais, M., Joiner, S., Sidle, K. C. L., Gowland, I., Collinge, J., Doey, L. J. & Lantos, P. (1997). The same prion strain causes vCJD and BSE. Nature 389, 448-450.
16. Ingrosso, L., Ladogana, A. & Pocchiari, M. (1995). Congo red prolongs the incubation period in scrapie-infected hamsters. Journal of Virology 69, 506-508.
17. Kimberlin, R. H. & Walker, C. A. (1983). The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection. Archives of Virology 78, 9-18.
18. Kimberlin, R. H. & Walker, C. A. (1986). Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions. Antimicrobial Agents and Chemotherapy 30, 409-413.
19. Ladogana, A., Casaccia, P., Ingrosso, L., Cibati, M., Salvatore, M., Xi, Y.-g., Masullo, C. & Pocchiari, M. (1992). Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. Journal of General Virology 73, 661-665.
20. Lasmézas, C. I., Deslys, J. P., Robain, O., Jaegly, A., Beringue, V., Peyrin, J. M., Fournier, J. G., Hauw, J. J., Rossier, J. & Dormont, D. (1997). Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275, 402-405.
21. Lazarini, F., Boussin, F., Deslys, J. P., Tardy, M. & Dormont, D. (1994). Astrocyte gene expression in experimental mouse scrapie. Journal of Comparative Pathology 111, 87-98.
22. Mackenzie, A. (1983). Immunohistochemical demonstration of glial fibrillary acidic protein in scrapie. Journal of Comparative Pathology 93, 251-259.
23. McKenzie, D., Kaczkowski, J., Marsh, R. & Aiken, J. (1994). Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection. Journal of Virology 68, 7534-7536.
24. Manuelidis, L., Fritch, W. & Xi, Y. G. (1997). Evolution of a strain of CJD that induces BSE-like plaques. Science 277, 94-98.
25. Manuelidis, L., Fritch, W. & Zaitsev, I. (1998). Dapsone to delay symptoms in Creutzfeldt-Jakob disease. Lancet 352, 456.
26. Medoff, G., Brajtburg, J., Kobayashi, G. S. & Bolard, J. (1983). Antifungal agents useful in therapy of systemic fungal infections. Annual Review of Pharmacology and Toxicology 23, 303-330.
27. Merz, P. A., Somerville, R. A., Wisniewski, H. M., Manuelidis, L. & Manuelidis, E. E. (1983). Scrapie-associated fibrils in Creutzfeldt-Jakob disease. Nature 306, 474-476.
28. Pocchiari, M., Schmittinger, S. & Masullo, C. (1987). Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. Journal of General Virology 68, 219-223.
29. Pocchiari, M., Casaccia, P. & Ladogana, A. (1989a). Amphotericin B: a novel class of antiscrapie drugs. Journal of Infectious Diseases 160, 795-802.
30. Pocchiari, M., Schmittinger, S., Ladogana, A. & Masullo, C. (1989b). Effects of amphotericin B in intracerebrally scrapie inoculated hamsters. In Unconventional Virus Diseases of the Central Nervous System, pp. 314-323. Edited by D. Dormont, L. A. Court, P. Brown & D. T. Kingsbury. Fontenay aux Roses: CEA Diffusion.
31. Pocchiari, M., Ingrosso, L., Cardone, F., Ladogana, A., Eleni, C. & Agrimi, U. (1996). Effect of amphotericin B on 263K and 139H strains of scrapie in Armenian hamsters. In Transmissible Subacute Spongiform Encephalopathies: Prion Diseases, pp. 185-190. Edited by L. Court & B. Dodet. Paris: Elsevier.
32. Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144.
33. Prusiner, S. B. (1992). Chemistry and biology of prions. Biochemistry 31, 12277-12288.
34. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27, 493-496.
35. Saint Julien, L., Joly, V., Seman, M., Carbon, C. & Yeni, P. (1992). Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycoses. Antimicrobial Agents and Chemotherapy 36, 2722-2728.
36. Somerville, R. A. & Dunn, A. J. (1996). The association between PrP and infectivity in scrapie and BSE infected mouse brain. Archives of Virology 141, 275-289.
37. Tagliavini, F., McArthur, R. A., Canciani, B., Giaccone, G., Porro, M., Bugiani, M., Lievens, P. M.-J., Bugiani, O., Peri, E., Dall'Ara, P., Rocchi, M., Poli, G., Forloni, G., Bandiera, T., Varasi, M., Suarato, A., Cassutti, P., Cervini, M. A., Lansen, J., Salmona, M. & Post, C. (1997). Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science 276, 1119-1122.
38. Weissmann, C. (1991). Spongiform encephalopathies. The prion's progress. Nature 349, 569-571.
39. Xi, Y. G., Ingrosso, L., Ladogana, A., Masullo, C. & Pocchiari, M. (1992). Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature 356, 598-601.